|
Volumn 116, Issue 3, 2001, Pages 354-359
|
Serum creatine kinase levels parallel the clinical course for rhabdomyomatous wilms tumor
a a a a a |
Author keywords
CK MB; Creatine kinase; Nephroblastoma; Rhabdomyoblast; Tumor marker; Wilms tumor
|
Indexed keywords
BIOCHEMICAL MARKER;
CREATINE KINASE;
CREATINE KINASE MB;
ABDOMINAL MASS;
ARTICLE;
CASE REPORT;
CREATINE KINASE BLOOD LEVEL;
DISEASE COURSE;
FEMALE;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
INFANT;
INFARCTION;
NEEDLE BIOPSY;
NEPHROBLASTOMA;
PRIORITY JOURNAL;
RHABDOMYOMA;
SEPTICEMIA;
TISSUE NECROSIS;
TUMOR RECURRENCE;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CREATINE KINASE;
DACTINOMYCIN;
DISEASE PROGRESSION;
DISEASE-FREE SURVIVAL;
DOXORUBICIN;
ETOPOSIDE;
FATAL OUTCOME;
FEMALE;
HUMANS;
IFOSFAMIDE;
INFANT;
KIDNEY NEOPLASMS;
MESNA;
NEOPLASM RECURRENCE, LOCAL;
NEPHRECTOMY;
REFERENCE STANDARDS;
RHABDOMYOMA;
TUMOR MARKERS, BIOLOGICAL;
VINCRISTINE;
WILMS TUMOR;
|
EID: 0034849927
PISSN: 00029173
EISSN: None
Source Type: Journal
DOI: 10.1309/HNDA-1RMT-63GP-52FU Document Type: Article |
Times cited : (5)
|
References (23)
|